Appendix 3G - Notification of issue, conversion or payment up of unquoted equity securities Announcement Summary Entity name PERCHERON THERAPEUTICS LIMITED Date of this announcement Friday November 06, 2026 The +securities the subject of this notification are: Other Total number of +securities to...
Notification regarding unquoted securities - PER
Filed with ASX · · 7 pages · English
Summary by 6ix AI
Percheron Therapeutics Limited has filed a notification regarding the issue of unquoted equity securities, specifically options expiring in the future. The filing details the issuance of two tranches of options, totaling a significant number of securities, as part of a placement announced earlier. The options will rank equally with existing securities in that class and were issued without cash consideration. The company has also indicated that security holder approval for the issue is being sought under listing rules.
Written by 6ix AI from the company’s filing. How 6ix writes summaries
Release
Percheron Therapeutics Limited on 6ix
Earlier from Percheron Therapeutics
- Update - Proposed issue of securities - PER
- Prospectus - Placement options and JLM options
- FDA Clearance for Vanderbilt Health Clinical Trial in AML
- Listing Rule waiver to allow quotation of PERAQ options
- Completion of HMBD-002 Drug Product Manufacture
Later from Percheron Therapeutics
- Application for quotation of securities - PER
- Top 20 Optionholders and Distribution List
- Change of Director's Interest Notice
- Updated Top 20 Option Holders Report
Follow Percheron Therapeutics into a list and get an email when it puts out news.
Follow Percheron Therapeutics